Genetic Engineering/Genomics

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Genetic Engineering/Genomics

Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders Price Single User $500.00 Site License $1,000.00 Global Site License $1,500.00 Publication Date: 12-Apr-2012 Format: PDF Pages: 4 Publisher: GlobalData More...

Next Generation Sequencing (NGS) Market by technology (pyrosequencing & others), competitors (Illumina, 454 Roche, Life Science Technologies), applications & tools - global trends & forecasts (2011 – 2016) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: Apr-2012 Format: PDF Pages: 271 Publisher: MarketsandMarkets Table of Contents Next Generation Sequencing (NGS) Market by Technology (Pyrosequencing & Others), Competitors (Illumina, 454 Roche, Life Science Technologies), Applications and Tools - Global Trends and Forecasts (2011-2016) Next generation sequencing is the next generation of DNA sequencing which includes several technologies to determine the order of nucleotide bases in a molecule of DNA. It is the fastest growing and the most lucrative segment in the genomics space. With estimated double digit growth, next generation sequencing will revolutionize the medical research in academic laboratories, biopharma, and the applied markets. The NGS market is dynamic and innovative; it is also paving its ways into the labs which were previously not involved in sequencing. High pace of NGS research is likely to boost the market for personal genome sequencing in the coming years. More...

Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: Feb-2012 Format: PDF Pages: 391 Publisher: MarketsandMarkets Table of Contents Life science and chemical instruments are used extensively in research and development activities, laboratories being one of the major users. Use of life science and chemical instruments for disease diagnosis is on a rise; for example, flow cytometers are used for diagnosis of all four types of leukemia. Life science and chemical equipment market is growing at a rapid rate due to the continuous requirement of these instruments in pharmaceutical and biotechnology industries. Besides, the increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity. All these factors are driving the life science and chemical instrumentation market. More...

Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 Price Single User $2,500.00 Site License $5,000.00 Global Site License $7,500.00 Publication Date: 09-Jan-2012 Format: PDF Pages: 112 Publisher: GlobalData More...

Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015 Price Single User $5,610.00 Enterprise Wide $7,710.00 Publication Date: Nov-2011 Format: PDF Pages: 644 Publisher: Axis Research Mind Report Brochure Report Description and Table of Contents

Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015 Price Single User $3,450.00 Enterprise Wide $5,550.00 Publication Date: Nov-2011 Format: PDF Pages: 342 Publisher: Axis Research Mind Report Brochure Report Description and Table of Contents

Global DNA & Gene Chip (Microarray) Market (2010 - 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: May-2011 Format: PDF Pages: 331 Publisher: MarketsandMarkets Table of Contents Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010. Gene Expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market. More...

Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 10-Feb-2011 Format: PDF Pages: 100 Publisher: GBI Research More...

Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Dec-2010 Format: PDF Pages: 124 Publisher: GBI Research Sample Pages GBI Research, the leading business intelligence provider, has released its latest report, “Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics” that provides key data, information and analysis of the major trends and issues in Personalized Medicine Market. The report provides a comprehensive insight into the role of Human Genomics and Proteomics to challenge traditional therapeutics. The report also provides a detailed analysis of market characterization of personalized medicine market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the patent landscape for human genomics and proteomics and provides comprehensive analysis. More...

Epigenetics Market Trends 2011 Please click here for more information or to purchase this report at our partner store Published: January 2011 Pages: 76 This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented associations of epigenetic modifications with diseases—especially various types of cancers. This report presents the biological role of various epigenetic modifications in vivo and frames them in the context of specific biological events such as differentiation and disease.

Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma Price Single User $3,500.00 Site License $7,000.00 Global Site License $10,500.00 Publication Date: 01-Sep-2010 Format: PDF Pages: 89 Publisher: GBI Research More...

DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 01-Dec-2009 Please click here for more information or to purchase this report at our partner store This report covers regional markets, products and services, evaluating them over the next five years, and profiles almost 40 companies involved in the DNA sequencing industry. It analyzes the market data of DNA sequencing tools and services in North America, Europe, Asia and the rest of the world. The report provides patent analysis with respect to competitors, geography and technology, and compares patenting trends over several years.

Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%) Publication Date: 10-Dec-2009 Please click here for more information or to purchase this report at our partner store Comprehensive analysis of the gene therapy clinical pipeline across all geographic and therapeutic markets, with key opinion leader insights. Identification of drivers and inhibitors to the commercial success of gene therapy.

Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics Price: $3,835.00 (€3,002.69) ($4,602.00 (€3,603.22) Including VAT at 20%) Publication Date: 01-Nov-2009 Please click here for more information or to purchase this report at our partner store This report identifies the leading companies at the forefront of epigenetic research that will drive the market to develop a new generation of therapies and diagnostics. It provides case studies of these firms developing epigenetic treatments to address cancer, neurodegenerative and infectious diseases.

MarketReports.com | Pharmaceuticals & Healthcare | Biotechnology |  Genetic Engineering/Genomics